Experiences of a High-Risk Population with Prenatal Hemoglobinopathy Carrier Screening in a Primary Care Setting: a Qualitative Study
-
Published:2017-10-05
Issue:3
Volume:27
Page:635-646
-
ISSN:1059-7700
-
Container-title:Journal of Genetic Counseling
-
language:en
-
Short-container-title:J Genet Counsel
Author:
Holtkamp Kim C. A., Lakeman Phillis, Hader Hind, Jans Suze M. J. P., Hoenderdos Maria, Playfair Henna A. M., Cornel Martina C., Peters Marjolein, Henneman LidewijORCID
Subject
Genetics(clinical)
Reference47 articles.
1. Aguilar Martinez, P., Angastiniotis, M., Eleftheriou, A., Gulbis, B., Mañú Pereira, M. D. M., Petrova-Benedict, R., et al. (2014). Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet Journal of Rare Diseases, 9, 1–7. 2. Ahmed, S., Bekker, H., Hewison, J., & Kinsey, S. (2002). Thalassaemia Carrier Testing in Pakistani Adults: Behaviour, Knowledge and Attitudes. Public Health Genomics, 5, 120–127. 3. Ames, A. G., Metcalfe, S. A., Dalton, A. A., Duncan, R. E., & Emery, J. (2015). Measuring informed choice in population-based reproductive genetic screening: a systematic review. European Journal of Human Genetics, 23, 8–21. 4. Brown, C. E., Wickline, M. A., Ecoff, L., & Glaser, D. (2009). Nursing practice, knowledge, attitudes and perceived barriers to evidence-based practice at an academic medical center. Journal of Advanced Nursing, 65, 371–381. 5. Brown, K., Dormandy, E., Reid, E., Gulliford, M., & Marteau, T. (2011). Impact on informed choice of offering antenatal sickle cell and thalassaemia screening in primary care: a randomized trial. Journal of Medical Screening, 18, 65–75.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|